PlainRecalls

GlaxoSmithKline Consumer Healthcare Holdings LLC

Compiled from official public sources by the publisher.

7 recalls on record · Latest: Nov 8, 2023

Subscribe to new GlaxoSmithKline Consumer He… recalls (RSS)

Agency notice ledger

Federal filing book GlaxoSmithKline Consumer He… LIGHT-BOOK · SINGLE-AGENCY

#1,933 of 14,151 · 7 notices · 0.007% archive

  • BOOK 7 notices
  • RANK #1,933 of 14,151
  • SHARE 0.007% archive
  • AGENCY FDA Drug (7)
  • CAT supplements
  • CATS 3 categories
  • LATEST Nov 8, 2023
  • PHOTO A I Foods Corporation

Nearest notice-volume peer: A I Foods Corporation (0 notice gap)

GlaxoSmithKline Consumer Healthcare Holdings LLC accounts for about 0.007% of the 104,423-notice archive on 7 distinct filings — a mid share signal beside absolute volume. FDA · CPSC · USDA FSIS · NHTSA notice stamps for this firm. Read with this firm → · Dominant category → · Similar-volume firm →

How GlaxoSmithKline Consumer He… compares to 14,151 recalling firms

GlaxoSmithKline Consumer Healthcare Holdings LLC ranks 1,933rd of 14,151 tracked firms by distinct recall-event count. Archive size reflects filing volume, not inherent product danger.

GlaxoSmithKline Consumer He… vs all firms by recall-notice count

Where this firm's archive sits among every tracked recalling manufacturer

7 1933rd of 14151 higher than 12,091 of 14,151 firms

Firms, banded by distinct federal recall-event inventory

Each bar is a band; taller bars hold more firms. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source FDA · CPSC · USDA FSIS · NHTSA federal recall filings · 2026-09-13

GlaxoSmithKline Consumer He… in the notice-volume neighbourhood

Distinct federal recall events among this firm and nearest nationwide peers

notices

What this shows GlaxoSmithKline Consumer Healthcare Holdings LLC holds about 0.007% of archive notices alongside 7 distinct filings.

Source FDA · CPSC · USDA FSIS · NHTSA filings aggregated by PlainRecalls As of September 2026
FDA Drug Moderate Nov 8, 2023

TUMS Antacid, Calcium Carbonate USP 1000 mg, Assorted Berries flavor, Chewable Tablets, packaged in 72-count bottles, Dist. by: GSK CH, Warren, NJ 07059. NDC: 135-0181-02, UPC 3-0766-0746-50-8
FDA Drug Moderate Nov 8, 2023

TUMS Antacid, Calcium Carbonate USP 1000 mg, Peppermint flavor, chewable tablets, 72-count bottle, Dist. by: GSK CH, Warren, NJ 07059. NDC: 0135-0228-06, UPC 3-0766-0745-85-3
FDA Drug Moderate Nov 8, 2023

TUMS Antacid, Calcium Carbonate USP 1000 mg, Assorted Berries flavor, chewable tablets, 72-count bottle, Dist. by: GSK CH, Warren, NJ 07059. NDC: 0135-0118-83, UPC 3-0766-0746-50-8
FDA Drug Moderate Nov 8, 2023

TUMS Antacid, Calcium Carbonate USP 1000 mg, Peppermint flavor, chewable tablets, packaged in 12-count roll, Dist. by: GSK CH, Warren, NJ 07059. NDC: 0135-0228-01, UPC 3-0766-0746-80-5
FDA Drug Moderate Nov 8, 2023

TUMS Antacid, Calcium Carbonate USP 1000 mg, Assorted Fruit flavor, Chewable Tablets, packaged in 160-count bottles, Dist. by: GSK CH, Warren, NJ 07059. NDC: 0135-0118-14, UPC 3-0766-0746-10-2
FDA Drug Moderate Nov 8, 2023

TUMS Antacid, Calcium Carbonate USP 1000 mg, Assorted Berries flavor, Chewable Tablets, packaged in 265-count bottle, Dist. by: GSK CH, Warren, NJ 07059. NDC: 135-0181-05, UPC 3-0766-3072-14-7
FDA Drug Moderate Nov 8, 2023

TUMS Antacid, Calcium Carbonate USP 1000 mg, Assorted Berries flavor, Chewable Tablets, packaged in 12-count roll, Dist. by: GSK CH, Warren, NJ 07059. NDC: 135-0181-03, UPC 3-0766-0746-70-6

GlaxoSmithKline Consumer He… holds a measurable archive slice

Drug and device firms outside this manufacturer and state, matched by notice volume and category footprint.

Similar supplements volume

Nearest multi-notice firms that share this firm's dominant product category.

Kirkman Group Inc. 7 Let's Talk Health, Inc. 7 Nubreed Nutrition, Inc 7 The Sausage Maker, Inc. 7

Frequently Asked Questions

How many federal recall notices name GlaxoSmithKline Consumer He…? ▼
PlainRecalls indexes 7 distinct federal recall events naming GlaxoSmithKline Consumer Healthcare Holdings LLC, aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (archive as of September 2026). That count is an issuance inventory, not a hazard score.
Where does GlaxoSmithKline Consumer He… sit among other recalling firms? ▼
GlaxoSmithKline Consumer Healthcare Holdings LLC ranks #1,933 of 14,151 by distinct recall-event count among 14,151 firms in this archive (85th percentile of firms with fewer notices). Rank tracks filing frequency, not product danger.
Which agency issues most of GlaxoSmithKline Consumer He…'s notices? ▼
FDA Drug accounts for 7 of this firm's 7 indexed notices.
What product category dominates GlaxoSmithKline Consumer He…'s filing book? ▼
Filings for GlaxoSmithKline Consumer Healthcare Holdings LLC span 3 product categories, led by supplements. Browse that category archive for peer firms and related notices.
Is a higher notice count more dangerous? ▼
No. Archive size reflects how often federal agencies publish recalls naming the firm — reporting volume, coverage, and product range all move the number. Always verify the individual notice with the issuing agency before acting on a specific product.
GlaxoSmithKline Consumer Healthcare Holdings LLC: 7 federal recall notices aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (lead agency FDA Drug). Verify individual notices with FDA directly before acting on a specific recall.

Firm-level totals aggregate distinct federal recall events naming GlaxoSmithKline Consumer Healthcare Holdings LLC; individual notices remain authoritative on each linked recall page.

Methodology · Corrections · FDA · CPSC · USDA FSIS · NHTSA · Archive as of September 2026